卒中后认知障碍的替代分子生物标志物:叙述性综述
该叙述性综述探讨分子生物标志物作为卒中后认知功能下降预后因素的现有研究,特别关注所用方法的神经心理学严谨性。文章呈现了生物标志物变化与整体认知表现及特定受累认知域相关的数据,旨在为卒中康复管理的科学共识建立提供依据。目前这些生物标志物的预测价值尚无共识。
要点
- 卒中后认知障碍常影响语言、记忆、注意和执行功能等多个认知域。
- 血浆或血清分子生物标志物浓度变化与卒中后认知表现受损相关。
- 现有生物标志物对卒中后认知下降的预测价值尚缺乏共识。
核心结论
- 分子生物标志物可作为卒中后认知下降的有用预测因子,但其预测价值尚未达成共识。
研究设计与样本
- 叙述性综述,审视现有关于分子生物标志物作为卒中后认知恶化预后因素的研究,重点关注方法的神经心理学严谨性。
主要发现
- 卒中后大脑发生神经化学改变,导致血浆或血清中多种生物标志物浓度变化,并与认知表现受损相关。
- 综述呈现了生物标志物变化与整体认知表现及特定受累认知域相关的数据。
临床怎么用
- 关注分子生物标志物用于早期评估卒中后认知下降风险,以支持实施高效且个性化的治疗干预。
局限性
- 现有生物标志物对卒中后认知下降的预测价值仍无共识。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cognitive impairment is a clinical condition that frequently occurs after stroke, interfering with patients' functional status and increasing their risk of death. Multiple cognitive domains can be affected, including language, memory, attention, and executive functions. Current research highlights the clinical value of tools for early assessment of cognitive decline risk, enabling implementation of efficient and personalized treatment interventions. In this respect, surrogate molecular biomarkers have been identified as useful predictors of poststroke cognitive decline. After a stroke, the brain undergoes neurochemical alterations, leading to changes in the concentration of several biomarkers, which can be detected in the plasma or serum of patients and have been associated with impaired cognitive performance. However, there is still no consensus on the predictive value of those biomarkers. The present narrative review examines existing research on molecular biomarkers as a prognostic factor for poststroke cognitive deterioration, with a specific focus on the neuropsychological rigor of the methodologies used in these studies. Particularly, data concerning biomarker variations in relation to global cognitive performance and the specifically affected cognitive domains are presented. The aim is to contribute to the establishment of a scientific consensus regarding the management of stroke recovery.
引用
- Gorostiola-Oyarzabal N, Joya A, Freijo Guerrero MDM, et al. Surrogate Molecular Biomarkers for Poststroke Cognitive Impairment: A Narrative Review. Stroke. 2025. PMID: 40776892. doi:10.1161/STROKEAHA.124.050507
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。